Prenetics Global Limited's Customers Performance

PRE

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


PRE's Source of Revenues		During the corresponding time, Prenetics Global Limited recorded a revenue increase by 201.94 % year on year, While revenue at the Prenetics Global Limited's corporate clients • List of PRE Customers

for the same period Prenetics Global Limited recorded revenue increase by 201.94 % year on year,

• List of PRE Customers

Prenetics Global Limited's Business Units


Goods transferred at a point in time	85.78 %	of total Revenue
Services transferred at a point in time	14.1 %	of total Revenue
Services transferred overtime	0.77 %	of total Revenue
Prevention - genetic testing	14.1 %	of total Revenue
Consumer health - health and wellness solutions	65.53 %	of total Revenue
Consumer health - sports distribution	21.02 %	of total Revenue
Prevention	14.1 %	of total Revenue
Prevention segments	14.1 %	of total Revenue
Consumer Health segments	86.55 %	of total Revenue
Hong Kong	25.13 %	of total Revenue
The United States	75.52 %	of total Revenue
Discontinued operations	10.46 %	of total Revenue
Discontinued operations Hong Kong	2.61 %	of total Revenue
Discontinued operations United Kingdom	1.96 %	of total Revenue
Discontinued operations Taiwan	5.27 %	of total Revenue
Discontinued operations Rest of the world	0.63 %	of total Revenue
Discontinued operations Services transferred at a point in time	10.46 %	of total Revenue
Discontinued operations Diagnostics - sale of precision oncology services	10.46 %	of total Revenue
Discontinued operations Prevention and Diagnostics	10.46 %	of total Revenue
Discontinued operations ACT genomics	10.46 %	of total Revenue
Discontinued operations ACT genomics Hong Kong	2.61 %	of total Revenue
Discontinued operations ACT genomics United Kingdom	1.96 %	of total Revenue
Discontinued operations ACT genomics Taiwan	5.27 %	of total Revenue
Discontinued operations ACT genomics Rest of the world	0.63 %	of total Revenue
Discontinued operations ACT genomics Services transferred at a point in time	10.46 %	of total Revenue

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Prenetics Global Limited's Comment on Sales, Marketing and Customers

The Company’s Non-life business is produced both through brokers and through direct relationships with insurance companies. In North America, business is primarily written through brokers, while in the rest of the world, the business is written on both a direct and broker basis.
The Company had two brokers that individually accounted for 10% or more of its total Non-life gross premiums written: Marsh (including Guy Carpenter) accounted for approximately 27% of total Non-life gross premiums written; and the Aon Group (including the Benfield Group) accounted for approximately 22% of total Non-life gross premiums written.